|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/26 | (2006.01) |
| (11) | Number of the document | 4121007 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21722538.2 |
| Date of filing the European patent application | 2021-03-19 | |
| (97) | Date of publication of the European application | 2023-01-25 |
| (45) | Date of publication and mention of the grant of the patent | 2025-07-02 |
| (46) | Date of publication of the claims translation | 2025-09-25 |
| (86) | Number | PCT/IB2021/000155 |
| Date | 2021-03-19 |
| (87) | Number | WO 2021/186245 |
| Date | 2021-09-23 |
| (30) | Number | Date | Country code |
| 202062992746 P | 2020-03-20 | US | |
| 202063027263 P | 2020-05-19 | US |
| (72) |
YOSHIDA, Nobuo , JP
SAKURAMOTO, Naomi , JP
SAKAGUCHI, Takahisa , JP
KITO, Hirokazu , JP
OZAWA, Takahiro , JP
JOSHI, Anjali , US
HSU, Yung Yueh , US
SOUILLAC, Pierre , US
|
| (73) |
Eisai R&D Management Co., Ltd. ,
6-10 Koishikawa, 4-Chome
Bunkyo-Ku, Tokyo 112-8088,
JP
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnų prieš beta amiloido peptido protofibriles didelės koncentracijos preparatai ir jų naudojimo būdai |
| HIGH CONCENTRATION ANTI-AMYLOID BETA PEPTIDE PROTOFIBRIL ANTIBODY FORMULATIONS AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2026-03-03 | 6 | 139.00 EUR |
| 2027-03-19 |